CIK 0001160308
- Non-accelerated filer
- Smaller reporting company
Savara Inc
Sign in to watch- Ticker
- SVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841318182
- Phone
- +51 285113796
- Business address
- 6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 72 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-16 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Gift | −128,995 | 1,188,050 | ||
| 2025-12-14 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −195,705 | $6.92 | $1.4M | 1,317,045 |
| 2025-12-10 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Gift | −23,629 | 1,512,750 | ||
| 2024-12-16 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Sale | −54,702 | $3.31 | $181K | 1,536,379 |
| 2024-12-13 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −92,593 | $3.21 | $297K | 1,591,081 |
| 2024-12-12 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Grant or award | +400,000 | 1,683,674 | ||
| 2024-12-12 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +900,000 | 900,000 | ||
| 2023-12-28 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Sale | −84,000 | $4.71 | $396K | 1,302,674 |
| 2023-12-28 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Gift | −19,000 | 1,283,674 | ||
| 2023-12-14 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −109,680 | $4.45 | $488K | 936,674 |
| 2023-12-14 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Grant or award | +450,000 | 1,386,674 | ||
| 2023-12-14 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +225,000 | 225,000 | ||
| 2022-12-13 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Grant or award | +325,000 | 1,046,354 | ||
| 2022-12-13 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +700,000 | 700,000 | ||
| 2021-12-31 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −62,318 | $1.24 | $77K | 721,354 |
| 2021-12-14 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Grant or award | +400,000 | 783,672 | ||
| 2021-12-14 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2021-12-08 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Purchase | +6,500 | $1.06 | $7K | 383,672 |
| 2021-12-02 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Purchase | +10,000 | $1.10 | $11K | 377,172 |
| 2021-11-19 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Purchase | +10,000 | $1.11 | $11K | 365,022 |
Page 1 of 2 · 40 trades